Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Emerson introduces AVENTICS Smart Pneumatics Analyzer May 31, 2019 Ford Equips Assembly Workers with Exoskeletons August 30, 2018 GAM releases helical rack and pinion systems May 23, 2019